Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Awaiting price reaction for this filing.
ADS Diagnostic Limited reported strong financial performance for FY2025-26 with revenue from operations growing 77.2% to Rs. 2,835.75 Lacs from Rs. 1,599.96 Lacs in the previous year. Net profit after tax increased 33% to Rs. 107.04 Lacs from Rs. 80.50 Lacs. The Board recommended a dividend of Rs. 1.20 per share (12%) for FY2025-26, subject to shareholder approval. However, operating cash flow turned negative at Rs. -3.86 Lacs compared to positive Rs. 77.73 Lacs in the prior year, primarily due to a significant increase in inventories (up Rs. 368.86 Lacs or 41%). Borrowings also increased by Rs. 79.37 Lacs to Rs. 310.15 Lacs. The auditor issued an unmodified opinion confirming the financial statements give a true and fair view.
Strong revenue and profit growth reflects robust business performance, but the negative operating cash flow and rising debt levels may raise concerns about working capital management. The company remains profitable and continues to reward shareholders with dividends.